ETNB Archived Articles
89bio (NASDAQ:ETNB): A Promising Clinical-Stage Biotech Tackling Liver and Cardiometabolic Diseases
Published on March 17, 2025
89bio, Inc. (NASDAQ:ETNB): Advancing Innovative Therapies for Liver and Cardiometabolic Diseases
Published on November 17, 2024
89bio, Inc. (NASDAQ:ETNB): A Promising Biopharmaceutical Company Advancing Innovative Therapies
Published on September 24, 2024